Biohaven Ltd. — Investor Relations & Filings
Filings indexed
240
across all filing types
Latest filing
2026-05-04
Prospectus
Country
VG
Virgin Islands (British)
Listing
US
BHVN
Biohaven Ltd. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas of focus are neuroscience, immunology, and oncology. Biohaven is advancing a portfolio of late- and early-stage drug development programs, building upon its legacy of success in transforming migraine treatment with Nurtec® ODT (rimegepant) and Zavzpret® (zavegepant). The company utilizes proprietary drug development platforms and combines internal research with intellectual property licensed from global institutions to address a broad range of rare and common diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 424B5 - Biohaven Ltd. (0001935979) (Filer) | 2026-05-04 | English | |
| 4 - Biohaven Ltd. (0001935979) (Issuer) | 2026-03-19 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | |
| 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41064217 | 424B5 - Biohaven Ltd. (0001935979) (Filer) | 2026-05-04 | English | ||
| 32990155 | 4 - Biohaven Ltd. (0001935979) (Issuer) | 2026-03-19 | English | ||
| 32900526 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900525 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900527 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900528 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900529 | 4 - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-04 | English | ||
| 32900530 | 8-K - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-02 | English | ||
| 32900531 | 10-K - BIOHAVEN LTD. (0001935979) (Filer) | 2026-03-02 | English | ||
| 13597694 | 8-K | 2026-01-12 | English | ||
| 13597695 | FORM 4 | 2026-01-08 | English | ||
| 13597697 | FORM 4 | 2026-01-08 | English | ||
| 13597696 | FORM 4 | 2026-01-08 | English | ||
| 13597698 | FORM 4 | 2026-01-08 | English | ||
| 13597699 | FORM 4 | 2026-01-08 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Anika Therapeutics, Inc.
A global joint preservation company developing solutions fo…
|
ANIK | US | Manufacturing |
|
ANIMALCARE GROUP PLC
Develops and commercializes veterinary pharmaceutical produ…
|
ANCR | GB | Manufacturing |
|
ANI PHARMACEUTICALS INC
Develops, manufactures, and markets branded, generic, and O…
|
ANIP | US | Manufacturing |
|
ANLON HEALTHCARE LIMITED
Researches and manufactures APIs, intermediates, and finish…
|
AHCL | IN | Manufacturing |
|
Annexin Pharmaceuticals AB
Clinical-stage biotech developing a cell-protecting biologi…
|
ANNX | SE | Manufacturing |
|
Annexon, Inc.
Clinical-stage biopharma developing complement medicines by…
|
ANNX | US | Manufacturing |
|
Antengene Corporation Limited
Global biopharma developing and commercializing novel oncol…
|
6996 | KY | Manufacturing |
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
Biohaven Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31890/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31890 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31890 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31890 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31890}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biohaven Ltd. (id: 31890)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.